5,7-Dihydroxy-3-[3-hydroxy-4-methoxy-5-(3-methylbut-2-enyl)phenyl]-2,3-dihydrochromen-4-one

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 异黄酮类化合物
• 英文名称: 5,7-Dihydroxy-3-[3-hydroxy-4-methoxy-5-(3-methylbut-2-enyl)phenyl]-2,3-dihydrochromen-4-one
• 化学式: C₂₁H₂₂O₆
• 分子量: 370.4
• InChiKey: GYRNAYOOXNCAQM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.5
• 重原子数：
  27
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.29
• 拓扑面积：
  96.2
• 氢给体数：
  3
• 氢受体数：
  6

文献信息

• S1PR2 antagonists and uses therefor
  申请人：DALHOUSIE UNIVERSITY

  公开号：US10487082B2

  公开（公告）日：2019-11-26

  Methods and compositions are provided for the treatment of familial exudative vitreoretinopathy (FEVR) through the administration of a therapeutically effective amount of a sphingosine-1-phosphate receptor type 2 (S1PR2) antagonist. Also provided herein are (Z)-3-((2,6-dichloropyridin-4-yl)amino)-3-(((4-isopropyl-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridin-6-yl)methyl)amino)acrylonitrile and analogs thereof, and their use in treating retinopathies and diseases characterized by insufficient angiogenesis.

  本文提供了通过施用治疗有效量的鞘氨醇-1-磷酸受体 2 型（S1PR2）拮抗剂治疗家族性渗出性玻璃体视网膜病变（FEVR）的方法和组合物。本文还提供了(Z)-3-((2,6-二氯吡啶-4-基)氨基)-3-(((4-异丙基-1,3-二甲基-1H-吡唑并[3,4-b]吡啶-6-基)甲基)氨基)丙烯腈及其类似物，以及它们在治疗视网膜病变和以血管生成不足为特征的疾病中的用途。
• S1PR2 ANTAGONISTS AND USES THEREFOR
  申请人：Dalhousie University

  公开号：EP3298014A1

  公开（公告）日：2018-03-28
• [EN] S1PR2 ANTAGONISTS AND USES THEREFOR<br/>[FR] ANTAGONISTES DE S1PR2 ET LEURS UTILISATIONS
  申请人：UNIV DALHOUSIE

  公开号：WO2016191872A1

  公开（公告）日：2016-12-08

  Methods and compositions are provided for the treatment of familial exudative vitreoretinopathy (FEVR) through the administration of a therapeutically effective amount of a sphingosine-1-phosphate receptor type 2 (S1PR2) antagonist. Also provided herein are compounds which contain bioisosteric replacements of the urea group of JTE- 013 and analogs thereof, and their use in treating retinopathies and diseases characterized by insufficient angiogenesis.